September 1, 2009 - Evaluation of results of a multicenter study indicates that quantitative evaluation of the progression of volume of extracranial carotid vessel walls is feasible with 1.5T magnetic resonance (MR) imaging, despite limitations due to patient motion or habitus.

In the study, Atherosclerotic Plaque Progression in Carotid Arteries: Monitoring with High-Spatial-Resolution MR Imaging — Multicenter Trial, researchers set out to estimate the annualized rate of progression of vessel-wall volume in the carotid arteries in 160 patients by using MR imaging and to establish the fraction of studies that have acceptable image quality.

One hundred sixty patients with greater than 50 percent narrowing of the diameter of the carotid artery were recruited at six centers for prospective imaging of the carotid arteries at baseline and one year later by using high-spatial-resolution, 1.5T MR imaging. Quantitative changes in atheroma volume were measured on unenhanced T1-weighted images. A multiple linear regression analysis was used to correlate progression with several clinical factors, including statin therapy.

All 160 patients completed both baseline and follow-up studies. Of these studies, 67.5 percent were deemed to have image quality that was acceptable for quantitative analysis. The causes of rejection were motion (46 percent), deep location of the carotid artery (22 percent), low bifurcation of the carotid artery (13 percent), and “other” (19 percent). The mean annual change in vessel-wall volume was 2.31 percent. At one-year follow-up, vessel-wall volumes in patients not receiving statin therapy had increased faster compared with those in patients receiving statin therapy: 7.87 percent, plus/minus 13.58 percent vs 1.14 percent, plus/minus 9.9 percent, respectively.

Researchers found that in patients who had preexisting carotid disease, the rate of increase in vessel-wall volume was slower in patients receiving statin therapy.

Reference: Boussel Lo?c, MD, PhD., et al. Atherosclerotic Plaque Progression in Carotid Arteries: Monitoring with High-Spatial-Resolution MR Imaging—Multicenter Trial. Radiology: Volume 252: Number 3—September 2009. radiology.rsnajnls.org.

For more information: www.rsna.org


Related Content

News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | Ultrasound Imaging

April 30, 2024 — Best Nomos, a TeamBest Global Company, is launching its most modern, highly innovative Compact SONALIS ...

Time April 30, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group, led by authors at the University of Toronto, have developed an approach for ...

Time April 23, 2024
arrow
News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Time April 22, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Population Health

April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with ...

Time April 04, 2024
arrow
Subscribe Now